Autism Diagnosis and Treatment in Children

News

EarliTec Diagnostics, Inc. Raises $21.5 Million in Series B Financing; Funds to Accelerate Commercialization of EarliPoint Evaluation and Further Product Development

Apr 2, 2024 admin

• Funding round led by Nexus NeuroTech Ventures and Venture Investors Health Fund • New

News

JAMA Publishes Two Large Studies Demonstrating the Diagnostic Accuracy of EarliTec’s Evaluation for Autism in Children as Young as 16 Months

Sep 5, 2023 admin

Data show that the clinically-validated, FDA-authorized EarliPointTM Evaluation for autism can provide objective, standardized, quantitative

News

EarliTec Diagnostics Receives FDA 510(k) Authorization for Next-Generation EarliPoint Evaluation for Autism

Jul 13, 2023 admin

The second generation of EarliPoint™ Evaluation uses a tablet to aid clinicians in diagnosing and

News

EarliTec Diagnostics Announces $19.5 Million Financing to Advance Autism Diagnosis and Treatment in Children as Young as 16 Months of Age

Feb 18, 2022 admin

EarliTec Diagnostics Announces $19.5 Million Financing to Advance Autism Diagnosis and Treatment in Children as